BCR-ABL Quantitative Real-Time PCR Kit

Quantitative Detection of BCR-ABL1 Major Transcript (e13a2 / e14a2)

The BCR-ABL Quantitative Real-Time PCR Kit is a CE-IVD molecular diagnostic test designed for the quantitative detection of BCR-ABL1 Major (p210) fusion transcript, the key molecular marker of the Philadelphia chromosome (t(9;22)).

This assay supports accurate CML diagnosis and treatment monitoring, enabling laboratories to measure molecular burden using a standardized real-time RT-PCR workflow.

Product Overview


The BCR-ABL Quantitative Real-Time PCR Kit is an in vitro diagnostic (IVD) assay based on quantitative real-time RT-PCR technology. It detects and quantifies BCR-ABL1 p210 transcripts from peripheral blood or bone marrow samples (EDTA).

The kit targets:

This ensures robust reporting for baseline disease burden and molecular response assessment during therapy.

Why BCR-ABL1 p210 Testing Matters


The presence of BCR-ABL1 fusion gene (Philadelphia chromosome) is strongly associated with Chronic Myeloid Leukemia (CML) and is a critical diagnostic marker in hematology-oncology.

Quantitative monitoring of the BCR-ABL1 p210 transcript level is essential to:

Targets Detected


Quantitative Target
  • BCR-ABL1 Major (p210)
    e13a2, e14a2
Internal Control
  • ABL1 Gene
    Ensures sample integrity and assay performance.

Applications


The kit is ideal for clinical molecular laboratories performing:

BCR-ABL Universal
  • BCR-ABL1 p210 quantitative testing
  • CML molecular diagnosis confirmation
  • baseline transcript burden assessment
  • longitudinal monitoring of treatment response
  • hematology-oncology molecular workflow integration

Key Features & Benefits


Quantitative Real-Time PCR for CML Monitoring

Designed specifically for quantitative detection of BCR-ABL1 p210, enabling accurate molecular testing in routine workflows.

Standardized Quantification Using QS Controls

Includes three Quantification Standards (QS1-QS3 dilutions) supporting reliable copy number estimation and calibration.

High Specificity with Probe-Based Detection

Real-time RT-PCR using specific fluorescent probes for BCR-ABL1 and ABL1 detection

Internal Control for Quality Assurance

ABL1 confirms RNA integrity and assay validity, strengthening confidence in every report.

Optimized for Fast & Automated Workflow

Compatible with the OnePCR-Rapi-Q Ultra-Fast POC System, supporting quick turnaround and simplified handling.

Sample Types & Reporting Output


Sample Types

Validated for use with:

  • Peripheral blood (EDTA)
  • Bone Marrow (EDTA)
Reporting Output

The test provides clear actionable output for clinicians and labs, including:

  • Positive / Negative interpretation
  • Ct values for BCR-ABL1 and ABL1
  • Amplification curves
  • Standard curve validity criteria
  • Quantification-ready QS calibration support
  • Result export options (system dependent)

Compatible System


OnePCR-Rapi-Q Ultra-Fast POC System

Designed for automated workflow including extraction and amplification.

OnePCR® workflow
  • Collect EDTA blood / bone marrow sample
  • Load 200 µl sample into Cartridge-1
  • Reconstitute Cartridge-2 tubes (RM + QS) using provided buffer
  • Load cartridges into the system
  • Fully automated extraction + RT-PCR run
  • Results displayed with Ct values, curves and interpretation

Storage & Stability


Ordering Information


Commercial Name Old Cat No. New Cat No. Pack Size
BCR-ABL Quantitative Real-Time PCR Kit G2M802821R G2M802821R 24 Tests

Why Choose the BCR-ABL Quantitative Real-Time PCR Kit


If your lab requires a reliable BCR-ABL1 p210 PCR kit for CML diagnosis and molecular monitoring, this product delivers:

  • consistent quantitative results
  • built-in assay validation (ABL1)
  • QS-based calibration support
  • high-confidence PCR performance
  • suitability for routine hematology molecular testing

Resources to get started


Download useful documents and technical information for the BCR-ABL Quantitative Real-Time PCR Kit.

Product Enquiry Form


Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.


© 2025 Genes2me. All rights reserved.